UnknownPhase 1

Conversion of Seddon III Nerve Injury to Seddon I/II Nerve Injury

United States10 participantsStarted 2016-05

Plain-language summary

This study will evaluate the safety and efficacy of PEG 3350 for use in nerve repair.

Who can participate

Age range16 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

* Isolated nerve transections of the digits, forearm, wrist, and palm will be included. * Class III nerve injury (Sunderland's 4th or 5th degree injury) * Nerve injuries that can be prepared using minimal or acceptable tension (according to surgeon discretion). * Pregnant and breastfeeding women cannot participate because of possible unknown and unpredictable risks to the unborn child. * Injuries beyond 24 hours will be excluded

What they're measuring

To demonstrate more rapid and increased return of function by PEG-fusion compared to the best current nerve repair techniques

Timeframe: 12 months

Trial details

NCT IDNCT03236064

SponsorWellSpan Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05

Contact for this trial

Richard C Trevino, MD

717-812-4090 rctrevino@trevino6.com

View on ClinicalTrials.gov More Injury of Other Nerves at Wrist and Hand Level of Unspecified Arm, Initial Encounter trials